Trial intelligence / Profile preview

Photodynamic therapy versus surgery for basal cell carcinoma skin lesions

RBR-4bdbpkCompleted

Sponsor
Hospital Amaral Carvalho
Start
Feb 2012
Modality
Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of 5-aminolevulinic acid and methyl aminolevulinate in basal cell carcinoma (BCC) (3 arms), sponsored by Hospital Amaral Carvalho. Started Feb 2012; status: completed.

02

Drugs

5-aminolevulinic acidmethyl aminolevulinate
03

Conditions

basal cell carcinoma (BCC)

Beyond the preview

Go deeper on RBR-4bdbpk.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-4bdbpk.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call